The development of cerebral venous thrombosis after tadalafil ingestion in a patient with antiphospholipid syndrome

5Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

We report a case of cerebral venous thrombosis related to the ingestion of tadalafil. A 45-year-old man presented with posterior headache and was diagnosed with tension headache. Five days later, he was transported to our hospital via ambulance due to a tonic-clonic seizure. Head MRI showed cerebral venous thrombosis (CVT). He confessed to having recently taken a large doses of tadalafil. His anti-cardiolipin antibody and anti-caldiolipin-β2-glycoprotein-I complex antibody levels were elevated. Our case suggests the possibility that tadalafil is related to both cardiovascular complications and CVT in patients with hypercoagulability. Patients with conditions associated with hypercoagulability, including antiphospholipid syndrome may be better advised to avoid the use of tadalafil.

Cite

CITATION STYLE

APA

Numata, K., Shimoda, K., Shibata, Y., Shioya, A., & Tokuda, Y. (2017). The development of cerebral venous thrombosis after tadalafil ingestion in a patient with antiphospholipid syndrome. Internal Medicine, 56(10), 1235–1237. https://doi.org/10.2169/internalmedicine.56.7864

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free